Belite Bio
(NASDAQ) BLTE
Belite Bio Financials at a Glance
Market Cap
$5.87B
Revenue (TTM)
$0.00
Net Income (TTM)
$77.61M
EPS (TTM)
$-2.30
P/E Ratio
-64.92
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$159.13
Volume
224,139
Open
$150.10
Price
$159.13
Volume
224,139
Open
$150.10
Previous Close
$159.44
Daily Range
$148.00 - $162.37
52-Week Range
$49.00 - $200.00
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$159.13
Volume
224,139
Open
$150.10
Previous Close
$159.44
Daily Range
$148.00 - $162.37
52-Week Range
$49.00 - $200.00
BLTE News
BLTE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Belite Bio
Industry
Pharmaceuticals
Sector
Health CareEmployees
25
CEO
Yue Hsin Lin, MD, PhD
Website
www.belitebio.comHeadquarters
San Diego, CA 92121, US
BLTE Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-17%
Return on Capital
-31%
Return on Assets
-27%
Earnings Yield
-1.54%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.87B
Shares Outstanding
39.34M
Volume
224.14K
Short Interest
0.00%
Avg. Volume
206.45K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$84.21M
EBITDA
$84.21M
Operating Cash Flow
$29.23M
Capital Expenditure
$151.00K
Free Cash Flow
$29.39M
Cash & ST Invst.
$145.15M
Total Debt
$537.00K
Belite Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$5.87B
N/A
Market Cap/Employee
$234.75M
N/A
Employees
25
N/A
Net Income
$25.32M
-150.7%
EBITDA
$30.77M
-305.9%
Quarterly Fundamentals
Net Cash
$275.10M
N/A
Accounts Receivable
$22.00K
N/A
Inventory
$0.00
N/A
Long Term Debt
$245.00K
N/A
Short Term Debt
$265.00K
N/A
Return on Assets
-27.48%
N/A
Return on Invested Capital
-30.70%
N/A
Free Cash Flow
$0.00
N/A
Operating Cash Flow
$0.00
N/A